Shandong Buchang Pharmaceuticals Co., Ltd. (603858.SS)
CNY 16.74
(-0.71%)
CNY 16.74
(-0.71%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 318.97 Million CNY | 118.57% |
| 2022 | -1.71 Billion CNY | -247.84% |
| 2021 | 1.16 Billion CNY | -37.55% |
| 2020 | 1.86 Billion CNY | -4.37% |
| 2019 | 1.94 Billion CNY | 3.05% |
| 2018 | 1.88 Billion CNY | 15.29% |
| 2017 | 1.63 Billion CNY | -7.43% |
| 2016 | 1.76 Billion CNY | -49.97% |
| 2015 | 3.53 Billion CNY | 167.2% |
| 2014 | 1.32 Billion CNY | 13.27% |
| 2013 | 1.16 Billion CNY | -6.61% |
| 2012 | 1.25 Billion CNY | 1.89% |
| 2011 | 1.22 Billion CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 117.4 Million CNY | 2.97% |
| 2024 Q3 | 81.44 Million CNY | -30.63% |
| 2024 Q1 | 114.01 Million CNY | 118.81% |
| 2023 Q2 | 290.86 Million CNY | -36.11% |
| 2023 Q4 | -606.17 Million CNY | -438.63% |
| 2023 Q3 | 179 Million CNY | -38.46% |
| 2023 Q1 | 455.26 Million CNY | 115.47% |
| 2023 FY | 318.97 Million CNY | 118.57% |
| 2022 FY | -1.71 Billion CNY | -247.84% |
| 2022 Q1 | 429.84 Million CNY | 2705.65% |
| 2022 Q2 | 388.53 Million CNY | -9.61% |
| 2022 Q3 | 448.48 Million CNY | 15.43% |
| 2022 Q4 | -2.94 Billion CNY | -756.07% |
| 2021 FY | 1.16 Billion CNY | -37.55% |
| 2021 Q4 | 15.32 Million CNY | -95.33% |
| 2021 Q3 | 327.87 Million CNY | -39.3% |
| 2021 Q2 | 540.19 Million CNY | 33.1% |
| 2021 Q1 | 405.86 Million CNY | -12.74% |
| 2020 FY | 1.86 Billion CNY | -4.37% |
| 2020 Q3 | 494.24 Million CNY | -17.24% |
| 2020 Q4 | 465.13 Million CNY | -5.89% |
| 2020 Q2 | 597.23 Million CNY | 96.28% |
| 2020 Q1 | 304.27 Million CNY | -49.03% |
| 2019 Q2 | 514.61 Million CNY | 81.09% |
| 2019 FY | 1.94 Billion CNY | 3.05% |
| 2019 Q4 | 596.95 Million CNY | 8.49% |
| 2019 Q3 | 550.24 Million CNY | 6.92% |
| 2019 Q1 | 284.17 Million CNY | -57.76% |
| 2018 Q4 | 672.76 Million CNY | 30.7% |
| 2018 Q1 | 206.23 Million CNY | -59.39% |
| 2018 FY | 1.88 Billion CNY | 15.29% |
| 2018 Q2 | 494.67 Million CNY | 139.85% |
| 2018 Q3 | 514.72 Million CNY | 4.05% |
| 2017 Q3 | 452.01 Million CNY | -0.8% |
| 2017 Q2 | 455.68 Million CNY | 104.91% |
| 2017 Q1 | 222.38 Million CNY | -56.47% |
| 2017 FY | 1.63 Billion CNY | -7.43% |
| 2017 Q4 | 507.86 Million CNY | 12.36% |
| 2016 Q3 | 653.27 Million CNY | 58.42% |
| 2016 Q1 | 192.86 Million CNY | -70.07% |
| 2016 Q4 | 510.86 Million CNY | -21.8% |
| 2016 FY | 1.76 Billion CNY | -49.97% |
| 2016 Q2 | 412.36 Million CNY | 113.81% |
| 2015 FY | 3.53 Billion CNY | 167.2% |
| 2015 Q4 | 644.5 Million CNY | 0.0% |
| 2014 FY | 1.32 Billion CNY | 13.27% |
| 2013 FY | 1.16 Billion CNY | -6.61% |
| 2012 FY | 1.25 Billion CNY | 1.89% |
| 2011 FY | 1.22 Billion CNY | 0.0% |